| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a5fa687c18fb1e33d4cc5317401f09e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2010208d6a966a6665ffdd20a71e898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_584f1e2cbabf1cfd7136782832852680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b465ba620b6335535c454453af9a705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f071a49615899def97c66256ea72c3a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_055483fe80e0f455d30b193ab1328bcc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9fa3302fbc93174568459523ff8d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9021d7776af2469582b008199b6163a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6741edcdf518b525863a792c000c7a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4b74e2abb2bfccda487ced9c6fb799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a778733a7abe75da2498f4e079822b94 |
| publicationDate |
2001-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0181623-A2 |
| titleOfInvention |
Neuronally expressed protein having apoptotic activity, and use thereof |
| abstract |
The invention relates to novel specifically expressed proteins, and to nucleic acid sequences or recombinant nucleic acid constructs encoding said proteins. The invention further relates to host organisms or transgenic animals containing said nucleic acid sequences or recombinant nucleic acid constructs, and to monoclonal or polyclonal antibodies directed to the isolated proteins. The invention also relates to a method for finding substances having a specific binding affinity to the inventive proteins, and to a method for the qualitative or quantitative analysis of the inventive nucleic acid sequences or inventive proteins. The invention further relates to the use of the nucleic acid sequences and proteins. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1284288-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1284288-A4 |
| priorityDate |
2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |